Title: Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 Diabetics Category: Health News Created: 3/14/2010 10:10:00 AM Last Editorial Review: 3/15/2010
Sernova Corp. (TSX VENTURE:SVA) today reported interim results from a key porcine diabetes study evaluating the safety and efficacy of the Cell Pouch System™. Interim results, to be presented at the American Society of Artificial Internal Organs 56th Annual Conference, Baltimore, MD, May 27th-29th in a podium presentation, confirm that the Cell Pouch System™ establishes a biological environment capable of preserving the functionality of therapeutic cells...
BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its iLase™ diode laser, the world's first personal laser for dentists and hygienists for performing a full-range of minimally invasive soft-tissue and hygiene procedures. The iLase is the first completely self-contained, hand-held dental laser that includes the laser, user interface, battery power, and controls in a single, integrated handpiece with no foot pedals or cords attached...
St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, announced several updates to its PressureWire(TM) platform, including a new marketing agreement with Siemens Medical Solutions USA, for the wireless PressureWire(TM) Aeris and the availability of the next-generation of PressureWire(TM) Certus technology, at the American College of Cardiology (ACC) and the Society of Interventional Radiology (SIR) annual meetings...